E

Enara Bio

49 employees

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2016

Funding rounds raised

Total raised

$18M

from 2 investors over 2 rounds

E

Enara Bio raised $18M on November 6, 2019

Investors: SV Life Sciences

E

Enara Bio raised undisclosed on December 1, 2018

Investors: RA Capital Management, L.P.

FAQ